The European Commission on Wednesday authorized the CCP virus vaccine developed by U.S. company Moderna, the second COVID-19 jab approved by the EU.
The authorization follows a positive recommendation from the European Medicines Agency (EMA), which reached the decision after an assessment of the vaccine’s quality, safety, and efficacy.
